Double-blind Comparative Study of E3810 Tablets (10 or 20 mg b.i.d.) to Evaluate Efficacy and Safety in Patients With Refractory Reflux Esophagitis
Clinical trial NCT00770913 · COMPLETED
Trial details
- NCT number
- NCT00770913
- Sponsor
- Eisai Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-10-01
- Primary completion
- 2009-11-01
- Enrollment
- 337
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.